Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis
- PMID: 20218123
Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis
Abstract
We compared the effectiveness of 2 treatment regimens for isoniazid-resistant tuberculosis (TB) in 42 patients attending a TB referral centre in the Islamic Republic of Iran. The patients were divided into 2 treatment groups: 26 received the 6-month standard HRZE treatment and 16 received a modified treatment of RZE for 6 months. There were no significant differences in age or sex of the groups. With the standard method of treatment, 21 (80.8%) patients were cured, 4 (15.4%) resulted in treatment failure, and 1 (3.8%) died. In the modified treatment group, 16 (100%) patients were cured, These differences were not statistically significantly different (P = 0.194).
Similar articles
-
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.Int J Tuberc Lung Dis. 2002 Nov;6(11):952-8. Int J Tuberc Lung Dis. 2002. PMID: 12475140
-
Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.East Afr Med J. 1999 Jun;76(6):307-13. East Afr Med J. 1999. PMID: 10750516
-
Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.Afr J Med Med Sci. 2000 Mar;29(1):51-3. Afr J Med Med Sci. 2000. PMID: 11379469 Clinical Trial.
-
Outpatient management of tuberculosis.Am Fam Physician. 1996 Apr;53(5):1579-94. Am Fam Physician. 1996. PMID: 8623687 Review.
-
[Treatment of tuberculosis].Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):122-9. doi: 10.1016/j.pneumo.2014.09.001. Epub 2014 Nov 27. Rev Pneumol Clin. 2015. PMID: 25434510 Review. French.
Cited by
-
Poor treatment outcome and associated risk factors among patients with isoniazid mono-resistant tuberculosis: A systematic review and meta-analysis.PLoS One. 2023 Jul 19;18(7):e0286194. doi: 10.1371/journal.pone.0286194. eCollection 2023. PLoS One. 2023. PMID: 37467275 Free PMC article.
-
Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.Curr Diab Rep. 2018 Aug 9;18(9):71. doi: 10.1007/s11892-018-1036-y. Curr Diab Rep. 2018. PMID: 30090969 Free PMC article. Review.
-
Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review.Front Med (Lausanne). 2023 Jun 20;10:1085010. doi: 10.3389/fmed.2023.1085010. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37415768 Free PMC article.
-
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.Lancet Respir Med. 2018 Apr;6(4):265-275. doi: 10.1016/S2213-2600(18)30078-X. Lancet Respir Med. 2018. PMID: 29595509 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources